Verastem Oncology
VSTM
#6412
Rank
NZ$1.35 B
Marketcap
NZ$17.93
Share price
-2.26%
Change (1 day)
100.93%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2025 (TTM): -NZ$0.42 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$13.37 Million. In 2024 the company made an earning of -NZ$0.23 Billion a decrease over its 2023 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.42 Billion85.36%
2024 -NZ$0.23 Billion49.31%
2023 -NZ$0.16 Billion18.36%
2022 -NZ$0.13 Billion3.67%
2021 -NZ$0.13 Billion5.43%
2020 -NZ$0.12 Billion-54.74%
2019 -NZ$0.26 Billion105.99%
2018 -NZ$0.13 Billion6.83%
2017 -NZ$0.12 Billion86.06%
2016 -NZ$63.08 Million-37.03%
2015 -NZ$0.11 Billion8.43%
2014 -NZ$92.38 Million29.52%
2013 -NZ$71.33 Million28.6%
2012 -NZ$55.46 Million133.9%
2011 -NZ$23.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-NZ$56.36 Million-86.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-5,019.45%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.30 B-653.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.13 B-3,969.69%๐Ÿ‡ฌ๐Ÿ‡ง UK